Arthritis D001168

Diseases [C] » Musculoskeletal Diseases [C05] » Joint Diseases » Arthritis

Description

Acute or chronic inflammation of JOINTS.   MeSH

Hierarchy View

Subtype Terms (12)

Arthritis, Experimental
3 approved drugs

Arthritis, Infectious
16 drugs (11 approved, 5 experimental)

Arthritis, Juvenile
75 drugs (53 approved, 22 experimental)

Arthritis, Psoriatic
74 drugs (50 approved, 24 experimental)

Arthritis, Rheumatoid
530 drugs (211 approved, 319 experimental)

Chondrocalcinosis
3 approved drugs

Gout
93 drugs (57 approved, 36 experimental)

Osteoarthritis
301 drugs (135 approved, 166 experimental)

Periarthritis
4 drugs (3 approved, 1 experimental)

Rheumatic Fever
11 drugs (5 approved, 6 experimental)

Sacroiliitis
5 drugs (4 approved, 1 experimental)

Spondylarthritis
10 drugs (8 approved, 2 experimental)



Organization Involved with Phase 4 Indications (262)

AARDS Research, Inc.

Abbott

AbbVie

Academic Medical Organization of Southwestern Ontario

Aga Khan University

American College of Rheumatology Research and Education Foundation

Amgen

Amsterdam Rheumatology and Immunology Center

Arthritic Center of Reno

Arthritis and Pain Associates of PG County

Arthritis and Rheumatic Disease Associates, P.C.

Arthritis & Rheumatism Associates, P.C.

Arthritis Treatment Center, Frederick, Maryland

ASST Gaetano Pini-CTO

Astellas

Azienda Ospedaliera Universitaria Senese Policlinico Santa Maria alle Scotte

Bangabandhu Sheikh Mujib Medical University

Barr Laboratories

Bassett Healthcare

Baxalta

Bristol-Myers Squibb

Cancer Research Network

Cantonal Hospital of St. Gallen

Celgene

Centocor

Central Hospital of Kanta-Hame

Central Maine Orthopaedics, PA

Central South University

Centre Hospitalier Régional d'Orléans

CHENLIJI Pharmaceutical Company

Chiba University

China Medical University

CHINESE RHEUMATISM DATA CENTER

Chinese SLE Treatment And Research Group

Chinese University of Hong Kong

Chong Kun Dang Pharmaceutical

Chosun University

CHR ORLEANS

Chung Shan Medical University

Columbia University

Crafoord Foundation

Dartmouth University

Department of Veteran Affairs

Depolabo

Diakonhjemmet Hospital

Dong-A Pharmaceutical

Duke University

Dutch Arthritis Association

Eisai

Eli Lilly

Erasmus University Rotterdam

Eulji University

European Commission

Exactech

Fatima Memorial Hospital

Fauji Foundation Hospital, Rawalpindi

Feinstein Institute for Medical Research

First People's Hospital of Foshan

Flinders University

Forest Laboratories

François Rabelais University

Fraunhofer

Free University of Amsterdam

French Society of Rheumatology

Fundação de Amparo à Pesquisa do Estado de São Paulo

Gaylis, Norman B., M.D.

Genentech

Georgetown University

Goupe d'Etudes et de Recherche Clinique En Rhumatologie

Government of Finland

Government of France

Government of Norway

Government of Pakistan

Gyeongsang University

Halozyme Therapeutics

Harvard University

Henry Ford Health System

Hoosier Cancer Research Network

Horizon Pharma

hospital universitario marques Valdecilla

Humboldt University

Immunex

Incyte

Innovaderm

Inova Health System

Iraj Sabahi Research Inc.

Iris Pharma

Istituto Ortopedico Gaetano Pini

Jagiellonian University

Janssen Pharmaceutica NV

Japan Biological Agent Study Integrated Consortium

Jawaharlal Institute of Postgraduate Medical Education and Research

J. Dietl Hospital, Krakow

Jiao Tong University

Johnson and Johnson

J. W. Goethe University

Karolinska Institute

Katholieke Universiteit Leuven

Keimyung University

Keio University

King Edward Medical University

Korea University

Kosin University

K. Papp Clinical Research

Kuopio University Hospital

Kyowa Hakko Kirin

Kyung Hee University

Lappi Central Hospital

Laval University

Leiden University

Lille Catholic University

Lincoln Medical and Mental Health Center

Loughborough University

Ludwig Boltzmann Institute

Lund University

Maastricht University

Maimonides Medical Center

Mallinckrodt

Mario Negri Institute

Martina Hansen's Hospital

Mashhad University of Medical Sciences

McGill University

Medac

Medical College of Wisconsin

Medical University Innsbruck

Medical University of Graz

Medical University of Vienna

Michael Schiff, MD

Michigan State University

Mundipharma

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Nazilli State Hospital

New York University

NHS Borders

NHS Fife

NHS Lothian

Northumbria Healthcare NHS Foundation Trust

Norwegian University of Science and Technology

Novartis

Ono Pharmaceuticals

OrthoCarolina Research Institute

Orton Invalid Foundation

Osaka University

Pakistan Institute of Medical Sciences

Parexel

Peking University

People's Liberation Army of China

Pfizer

Pharma Consulting Group AB

Postgraduate Institute of Medical Education and Research

Probity Medical Research

Qilu Hospital of Shandong University

Reade Rheumatology Research Institute

Regeneron

Region Skane

Rheumatism Foundation Hospital

Rheumatism Hospital Graasten

Rheumatology Associates of Baltimore, L.L.C.

Roche

Rouen Normandy University

Rush University

Saitama Medical University

Samsung

Sanofi

Schiff, Michael, M.D.

Second Military Medical University

Seinajoki Central Hospital

Seoul National University

Shandong University

Shanghai Pharmaceuticals Holding Co., Ltd

Shenzhen University

Shinshu University

Showa Inan General Hospital

Sichuan University

Simcere Pharmaceutical Co., Ltd

Singapore General Hospital

Sohag University

Soonchunhyang University

South-Eastern Norway Regional Health Authority

Spanish Foundation of Rheumatology

Sponsor GmbH

Stanford University

State of New York

Sun Yat-Sen University

SURPRISE Study Group

Taipei Veteran General hospital

Tanta University

Technion University

Tel Aviv University

The Arthritis Clinic of Northern Virginia, P.C.

The Arthritis Society, Canada

The Christ Hospital

The Danish Psoriasis Association

The Danish Rheumatism Association

Theorem Clinical Research

The Swedish Research Council

The Swedish Rheumatism Association

Tsinghua University

Umanis

Universidad Autonoma de Barcelona

Universidad de Cordoba

Université catholique de Louvain

University Hospital of North Norway

University of Aberdeen

University of Alabama, Birmingham

University of Amsterdam

University of Bergen

University of Birmingham

University of Caen-Normandie

University of California, Los Angeles

University of California, San Francisco

University of Cantabria

University of Cincinnati

University of Copenhagen

University of Dundee

University of Erlangen-Nuremberg

University of Franche-Comté

University of Glasgow

University of Gothenburg

University of Groningen

University of Helsinki

University of L'Aquila

University of Leeds

University of Lille

University of London

University of Lyon

University of Maryland

University of Massachusetts

University of Missouri

University of Montreal

University of Nottingham

University of Oslo

University of Oxford

University of Paris

University of Pavia

University of Pittsburgh

University of Rennes

University of Rochester

University of Sao Paulo

University of Sherbrooke

University of South Australia

University of South Florida

University of Strasbourg

University of Tampere

University of Toronto

University of Toulouse

University of Turku

University of Ulsan

University of Vienna

University of Warwick

University of Washington

University of Western Ontario

Uppsala University

Utrecht University

Vastra Gotaland Region

Versus Arthritis

Vita-Salute University of Milano. Italy

Wenzhou Medical University

Wonkwang University

Wyeth

ZonMw: The Netherlands Organisation for Health Research and Development

Organization Involved with Phase 3 Indications (158)

Organization Involved with Phase 2 Indications (158)

Organization Involved with Phase 1 Indications (64)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.